Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 3 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  2. US 12180509

    Methods for reprograming non-pluripotent cells into pluripotent stem cells

    BeiHao Stem Cell and Regenerative Medicine Research Institute Co., Ltd. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  3. US 12171761

    Vilazodone inclusion complexes, compositions and preparation thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  4. US 12162821

    Treatment of cataplexy

    AXSOME MALTA LTD. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  5. US 12150461

    Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof

    Sovida Solutions Ltd. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  6. US 12145974

    Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  7. US 12133890

    Antigen-binding polypeptide targeting B7H3 and application thereof

    NINGBO T-MAXIMUM BIOPHARMACEUTICALS CO., LTD. · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  8. US 12134650

    Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  9. US 12128044

    Fused tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  10. US 12129258

    Diaryl macrocyclic compound and pharmaceutical composition, and use thereof

    PrimeGene (Beijing) Co., Ltd. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  11. US 12121542

    BCMA chimeric antigen receptor based on single domain antibody and use thereof

    SHENZHEN PREGENE BIOPHARMA CO., LTD. · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  12. US 12115150

    Biomarkers of coronavirus pneumonia

    RedHill Biopharma Ltd. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  13. US 12109296

    Peptide exhibiting wrinkle-improving activity and uses thereof

    CAREGEN CO., LTD. · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  14. US 12102609

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  15. US 12097185

    Compositions comprising ciprofloxacin and celecoxib

    NEUROSENSE THERAPEUTICS LTD. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  16. US 12090126

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  17. US 12072338

    Pharmaceutical peptides for the treatment of inflammatory diseases

    PROTAGONISTS LTD. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  18. US 12064502

    Peptide exhibiting wrinkle-improving activity and uses thereof

    CAREGEN CO., LTD. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  19. US 12064411

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  20. US 12059471

    Complex

    UNITED IMMUNITY, CO., LTD. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  21. US 12054556

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  22. US 12049487

    Universal chimeric antigen receptor T-cell preparation technique

    GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  23. US 12036194

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  24. US 12030970

    Curable composition and stereolithographic resin composition comprising same

    KURARAY CO., LTD. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted